Journal: Nature Communications
Article Title: Single cell transcriptomics of human psoriasis and epidermal specific Ube2l3 deficient mice highlight CXCL16/CXCR6 involvement in psoriasis development
doi: 10.1038/s41467-025-64106-6
Figure Lengend Snippet: a UMAP visualization of 398188 cells epidermal cells across control (CE) and Ube2l3 △Epi (UE) mice, classified into 6 immune/non-immune clusters via Louvain algorithm. Cell cluster: cyc-T, cycling T cell, Krt, keratinocytes, Mel, melanocytes, NK/T, natural kill T cells and T cells, SG, sebaceous gland. b Marker expression dot plot for the 6 cell populations. Dot size = expressing cell fraction; color intensity = mean scaled expression. c Compositional changes of epidermal cell states in CE vs. UE. d Predicted ligand-receptor interactions between clusters. Red arrow: upregulated Cxcl16 (myeloid)→ Cxcr6 (NK/T) axis in UE. e Signaling activity of CXCR6-CXCL16 and top ligand-receptor pairs across cell types. f Dot plot showing the differentially expressed Vγ2 and Vγ4 specified marker ( Tcrg-V4, 5830411N06Rik and Cd163l ) in T-cell subsets. g Flow cytometry: Increased IL-17A⁺CXCR6⁺CD3⁺ T cells in Ube2l3 △Epi mice epidermis. n = 6/group. h Flow cytometry plots and quantification of the percentage of Vγ2 and Vγ3 cells in γδT cells in Epi-Ctrl and Epi -Ube2l3 △Epi groups. Epi-Ctrl, n = 5, Epi -Ube2l3 △Epi , n = 6. i Flow cytometric analysis of the percentage of TNFa + and IL-17A + Vγ2 + cells in Vγ2 + γδT cells between Epi-Ctrl and Epi -Ube2l3 △Epi groups. Epi-Ctrl, n = 5, Epi -Ube2l3 △Epi , n = 6. j Schematic experimental design showing Ube2l3 △Epi mice treated with or without anti-Vγ2mAb (10ug/g/week) intraperitoneally in four weeks. k Representative phenotype of Ube2l3 △Epi mice treated with or without anti-Vγ2mAb before (Week 0) and after 4-week treatment (Week 4). Histological analysis of H&E staining was calculated and showed a decrease in Vγ2 antibody group. ( n = 5 per group). Immunofluorence analysis of Vγ2 (red) and CD3 (green) was showed. white triangle, double stained Vγ2 and CD3. l Proportion of L-17A + γδT cells in γδT in Epi-Ctrl, Epi -Ube2l3 △Epi and the epidermis of mouse Ube2l3 △Epi group treated with anti-Vγ2mAb (Epi- Ube2l3 △Epi - Vγ2Ab). Epi-Ctrl, n = 5, Epi -Ube2l3 △Epi , n = 6, Epi- Ube2l3 △Ep i- Vγ2Ab, n = 3. m FPKM of CXCR6 in GSE53552 (left, NL, n = 23, LS, n = 25, LS-treated, n = 20), GSE117239 (middle, NL, n = 34, LS, n = 34, LS-treated, n = 30), and GSE117239 (right, NL, n = 50, LS, n = 49, LS-treated, n = 45). n UMAP plots of CXCR6 expression in human lymphoid cells in NE and PE group. o Heatmap results showed the average expression of CXCR6 and other markers in 8 groups in human lymphoid cells. p Immunofluorescence staining of psoriatic skin for CD3 (green), CXCR6 (red), CD8 (purple), and DAPI (blue). White triangle indicated CXCR6 + and CD8 + T cells (Scale bar: 50 um). q Representative flow cytometric plots and percentage of IL-17A + CXCR6 + T cells in CD3 + T cells in Epi-HD ( n = 6) and Epi-PSO ( n = 3). The proportion of CD4 + and CD8 + in IL-17A + CXCR6 + T cells. Data are presented as mean ± SEM, and p -values were calculated by unpaired, two-tail student’s t -test ( g , h , i , k and q ), one-way ANOVA with Tukey’s multiple comparisons ( l , m ). The Figure j was created in BioRender. Chen, X. (2025) https://BioRender.com/854rwn9 .
Article Snippet: The experimental design is shown in Fig. . Anti-CXCL16: Mice received subcutaneous injections (s.c.) of 4 μg/g/week goat anti-mouse CXCL16 polyclonal antibody (AF503, R&D Systems) or goat IgG isotype control.
Techniques: Control, Marker, Expressing, Activity Assay, Flow Cytometry, Staining, Immunofluorescence